Mindfulness-based interventions for major depressive disorder: A comprehensive meta-analysis of randomized controlled trials.
Study Goal
The researchers aimed to evaluate the effectiveness of mindfulness-based interventions (MBIs) in reducing depressive symptoms in individuals with major depressive disorder (MDD) through a meta-analysis of randomized controlled trials.
Results Summary
The meta-analysis found that MBIs significantly reduced depressive symptoms immediately after the intervention, but this effect was not sustained at follow-up. The positive results were primarily driven by outlying studies, indicating the need for higher-quality RCTs with larger samples and longer durations to confirm findings.
Population
Individuals with a current episode of major depressive disorder (MDD).
Effective Dosage
Not specified in the abstract.
Duration
Not specified in the abstract.
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
mindfulness-based interventions (MBIs) | decrease | depressive symptoms | MDD subjects | SMD: -0.59, 95% CI: -1.01 to -0.17 | showed significant reduction | #1 |
mindfulness-based interventions (MBIs) | decrease | depression severity immediately after MBIs | - | - | was associated with reduction | #2 |
mindfulness-based interventions (MBIs) | no change | depression severity | - | - | not at follow up endpoint | #3 |
BACKGROUND: This is a meta-analysis of randomized controlled trials (RCTs) of mindfulness-based interventions (MBIs) for a current episode of major depressive disorder. METHODS: Both English (PubMed, PsycINFO, Embase, and Cochrane Library databases) and Chinese (WanFang and CNKI) databases were systematically and independently searched. Standardized mean differences (SMDs) and risk ratio (RR) ± their 95% confidence intervals (CIs) based on the random effects model were calculated. RESULTS: A total of 11 RCTs with 12 treatment arms (n = 764; MBIs = 363; and control group = 401) were identified and analyzed. Compared to the control group, MDD subjects receiving MBIs showed significant reduction in depressive symptoms (n =722; SMD: -0.59, 95% CI: -1.01 to -0.17, I CONCLUSION: This meta-analysis found that MBIs was associated with reduction of depression severity immediately after MBIs but not at follow up endpoint. Further, the positive effects of MBIs were mainly driven by outlying studies. Higher quality of RCTs with larger samples and longer study duration are needed to confirm the findings.